Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zong Sheng Guo

Showing results (21-30 of 42) with videos related to

Pageof 5
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2013
A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosisPragatheeshwar Thirunavukarasu, Magesh Sathaiah, Michael C Gorry, et al.
Journal of Cellular Biochemistry|July 28, 2015
TRAIL-Induced Caspase Activation Is a Prerequisite for Activation of the Endoplasmic Reticulum Stress-Induced Signal Transduction PathwaysDae-Hee Lee, Ki Sa Sung, Zong Sheng Guo, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapyZhi Zhu, Hongqi Chen, Chao Feng, et al.
Annals of Surgical Oncology|February 12, 2021
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic MalignanciesChigozirim N Ekeke, Kira L Russell, Kyla Joubert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2018
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 BlockadeStacy J Kowalsky, Zuqiang Liu, Mathilde Feist, et al.
Journal for Immunotherapy of Cancer|January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolyticsZong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunityMin Yang, Esther Giehl, Chao Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for GliomaBingtao Tang, Zong Sheng Guo, David L Bartlett, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safetyYan Ge, Haiyan Wang, Jinghua Ren, et al.
Cancer Immunology Research|August 31, 2017
The Antitumor Effects of Vaccine-Activated CD8<sup>+</sup> T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T CellsSha Wu, Wei Zhu, Yibing Peng, et al.
Pageof 5

Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 27, 2013
A rationally designed A34R mutant oncolytic poxvirus: improved efficacy in peritoneal carcinomatosisPragatheeshwar Thirunavukarasu, Magesh Sathaiah, Michael C Gorry, et al.
Journal of Cellular Biochemistry|July 28, 2015
TRAIL-Induced Caspase Activation Is a Prerequisite for Activation of the Endoplasmic Reticulum Stress-Induced Signal Transduction PathwaysDae-Hee Lee, Ki Sa Sung, Zong Sheng Guo, et al.
Journal for Immunotherapy of Cancer|July 24, 2025
Specific inhibitor to KRAS<sup>G12C</sup> induces tumor-specific immunity and synergizes with oncolytic virus for enhanced cancer immunotherapyZhi Zhu, Hongqi Chen, Chao Feng, et al.
Annals of Surgical Oncology|February 12, 2021
Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic MalignanciesChigozirim N Ekeke, Kira L Russell, Kyla Joubert, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 2, 2018
Superagonist IL-15-Armed Oncolytic Virus Elicits Potent Antitumor Immunity and Therapy That Are Enhanced with PD-1 BlockadeStacy J Kowalsky, Zuqiang Liu, Mathilde Feist, et al.
Journal for Immunotherapy of Cancer|January 11, 2019
Vaccinia virus-mediated cancer immunotherapy: cancer vaccines and oncolyticsZong Sheng Guo, Binfeng Lu, Zongbi Guo, et al.
Cancer Immunology, Immunotherapy : CII|February 4, 2021
IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunityMin Yang, Esther Giehl, Chao Feng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2020
Synergistic Combination of Oncolytic Virotherapy and Immunotherapy for GliomaBingtao Tang, Zong Sheng Guo, David L Bartlett, et al.
Journal for Immunotherapy of Cancer|March 27, 2020
Oncolytic vaccinia virus delivering tethered IL-12 enhances antitumor effects with improved safetyYan Ge, Haiyan Wang, Jinghua Ren, et al.
Cancer Immunology Research|August 31, 2017
The Antitumor Effects of Vaccine-Activated CD8<sup>+</sup> T Cells Associate with Weak TCR Signaling and Induction of Stem-Like Memory T CellsSha Wu, Wei Zhu, Yibing Peng, et al.
Pageof 5